PDE4B-targeting antisense oligonucleotide (OliPass)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePDE4B-targeting antisense oligonucleotide (OliPass)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionPhosphodiesterase 4B inhibitors
TargetsPhosphodiesterase 4B
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOlipass Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOlipass Co
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A